Tiziana Life Sciences has been notified that Gabriele Cerrone, its Chairman and Acting CEO, purchased 25,000 common shares at 58c per share, bringing his total holding to 38,640,737 common shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on TLSA: